Pain-related Long Covid in Covid-19 Survivors

Aalborg University

Status: Invitation-only

Conditions: COVID-19; Pain, Chronic

Treatments: Other: Questionnaire and register-based data assessment

Study type: Observational

Funder types: Other

Identifiers

NCT05520931

2021-056227

Details and patient eligibility

About

The exploratory project aims to investigate the presence of pain as a long Covid-19 symptom in previously hospitalised patients and in non-hospitalised persons previously tested positive in a PCR test.

Full description

The main objectives investigated will be to determine the general prevalence of pain symptoms In Covid-19 survivors, correlating and analysing the role of previously comorbidities in the development of pain symptom in Covid-19 survivors, and to understand the prevalence of pain related long Covid-19 symptoms for future characterisations. Hence, the projects main outcome will be to try to understand why som Covid-19 survivors develop persistant pain and others don't. Furthermore, the project plan to analyse gender and age differences, and data between Covid-19 waves as well as any possible association between pain prevalence and time after positive PCR-test.

Enrollment: 600,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Previously infected with SARS-CoV-2 virus

Exclusion criteria

• Participants under the age of 18
• Hidden/secret address/name
• No access to digital mail (the channel of data collection)

Trial design

600,000 participants in 2 patient groups

Hospitalization group

Description:

Previously hospitalized Covid-19 survivors who have been admittet to the hospital with or because of SARS-CoV-2 infection. Time from infection date start is \> 6 months. The group is anticipated to encompass 2.182 privously hospitalized adult patients.

Treatment:

Other: Questionnaire and register-based data assessment

PCR+ group

Description:

Non-hospitalized Covid-19 survivors that has previously testet positive in an Polymerase chain reaction test without being admittet to the hospital. Time from infection data start is \> 6 months. The group will include almost the total population of adults who have tested positive in a Polymerase Chain Reaction test. Those with secret adresses and those without access to digital mail (information channel of the questionnaire) will be excluded being approcimatelyh 7% of 650.000 possible participants. The group encompasses 593.741 participants.

Treatment:

Other: Questionnaire and register-based data assessment